Literature DB >> 16606359

Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons.

Qiu-Fu Ge1, Er-Qing Wei, Wei-Ping Zhang, Xin Hu, Xiao-Jia Huang, Lei Zhang, Ying Song, Zhen-Qiu Ma, Zhong Chen, Jian-Hong Luo.   

Abstract

5-Lipoxygenase (5-LOX) is the enzyme metabolizing arachidonic acid to produce pro-inflammatory leukotrienes. We have reported that 5-LOX is translocated to the nuclear envelope after ischemic-like injury in PC12 cells. In the present study, we determined whether 5-LOX is activated (translocation and production of leukotrienes) after oxygen-glucose deprivation (OGD) in primary rat cortical neurons; if so, whether this activation is mediated by NMDA receptor. After OGD, 5-LOX was translocated to the nuclear envelope as detected by immunoblotting, immunostaining and green fluorescent protein-5-LOX transfection. 5-LOX metabolites, cysteinyl-leukotrienes (CysLTs) but not leukotriene B4, in the culture media were increased 0.5-1.5 h after recovery. Similarly, NMDA (100 microm) also induced 5-LOX translocation, and increased the production of CysLTs during 0.5-1 h NMDA exposure. Both OGD and NMDA reduced neuron viability. NMDA receptor antagonist MK-801 inhibited almost all the responses to OGD and NMDA; whereas 5-LOX activating protein inhibitor MK-886 and 5-LOX inhibitor caffeic acid inhibited the reduction of neuron viability and the production of CysLTs, but did not affect 5-LOX translocation. From these results, we conclude that OGD can activate 5-LOX in primary rat cortical neurons, and that this activation may be partly mediated via activating NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606359     DOI: 10.1111/j.1471-4159.2006.03828.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.

Authors:  Le Wu; Sen Miao; Lin-Bing Zou; Ping Wu; Hua Hao; Ke Tang; Pan Zeng; Jing Xiong; Hong-Hua Li; Qiang Wu; Lei Cai; Du-Yun Ye
Journal:  J Mol Neurosci       Date:  2012-06-03       Impact factor: 3.444

2.  Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.

Authors:  Richard C Li; Bodduluri Haribabu; Steven P Mathis; Jinkwan Kim; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

3.  Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells.

Authors:  Cheng-tan Li; Wei-ping Zhang; San-hua Fang; Yun-bi Lu; Li-hui Zhang; Ling-ling Qi; Xue-qin Huang; Xiao-jia Huang; Er-qing Wei
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

4.  5-Lipoxygenase inhibitor zileuton inhibits neuronal apoptosis following focal cerebral ischemia.

Authors:  Song-sheng Shi; Wei-zhong Yang; Xian-kun Tu; Chun-hua Wang; Chen-mei Chen; Yan Chen
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Nuclear translocation of cysteinyl leukotriene receptor 1 is involved in oxygen-glucose deprivation-induced damage to endothelial cells.

Authors:  San-hua Fang; Ka-na Lin; Xue-qin Huang; Yun-bi Lu; Wei-ping Zhang; Er-qing Wei
Journal:  Acta Pharmacol Sin       Date:  2012-10-22       Impact factor: 6.150

6.  Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.

Authors:  Xue-Qin Huang; Xia-Yan Zhang; Xiao-Rong Wang; Shu-Ying Yu; San-Hua Fang; Yun-Bi Lu; Wei-Ping Zhang; Er-Qing Wei
Journal:  J Neuroinflammation       Date:  2012-06-26       Impact factor: 8.322

7.  Esculetin inhibits N-methyl-D-aspartate neurotoxicity via glutathione preservation in primary cortical cultures.

Authors:  Chang-Ryul Lee; Eun-Joo Shin; Hyoung-Chun Kim; Yeon-Sik Choi; Taekyun Shin; Myung-Bok Wie
Journal:  Lab Anim Res       Date:  2011-09-30

Review 8.  Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.

Authors:  Paolo Gelosa; Francesca Colazzo; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.